Work

Transdermal radiofrequency (V ERASER®) plus polidocanol sclerotherapy versus polidocanol sclerotherapy alone for the treatment of reticular veins and telangiectasias. A randomized controlled trial (TYPER trial)

Year: 2025

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Phlebology The Journal of Venous Disease

DOI: 10.1177/02683555251375384

Authors: Rebeca Higino Becker, Roberto Augusto Caffaro, Caroline Cândida Carvalho de Oliveira, Rafaela Palermo Marcondes, Ariadne Ribeiro Negrão, Flávia Magella, Giuliano Giova Volpiani, Samantha Neves, Renata Camila Barros Rodrigues, Mariana Ferreira Borges Firmo Rodrigues, Viviane Santana da Silva, Camilla Moreira Ribeiro, Rodrigo Kikuchi, Fabricio Rodrigues Santiago, Eduardo Ramacciotti

Institutions: Faculdade de Ciências Médicas da Santa Casa de São Paulo, Centro Universitário São Lucas, Universidade Federal do Rio Grande, Universidade Federal de Goiás, Loyola University Medical Center, Loyola Medicine

Language: English

Topic: Diagnosis and Treatment of Venous Diseases

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4413988673

FWCI:

Cites: 15

Cited by:

Related to: 10